| |
 |
|
Class Information
Number: 424/144.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds receptor > Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., nk cell, etc.)
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a receptor integral to or derived from a lymphocytic or a lymphocytic-like cell.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7622116 |
Method of treating inflammation using soluble IL-17RCX4 |
Nov. 24, 2009 |
| 7618630 |
Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
Nov. 17, 2009 |
| 7618632 |
Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies |
Nov. 17, 2009 |
| 7618633 |
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
Nov. 17, 2009 |
| 7611708 |
Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
Nov. 3, 2009 |
| 7605238 |
Human CTLA-4 antibodies and their uses |
Oct. 20, 2009 |
| 7604800 |
Anti-PSGL-1 antibodies |
Oct. 20, 2009 |
| 7597887 |
KIM-1 antagonists and use to modulate immune system |
Oct. 6, 2009 |
| 7595045 |
Anti-.alpha.9 integrin antibody and the use thereof |
Sep. 29, 2009 |
| 7592004 |
Stable lyophilized pharmaceutical formulation of IgG antibodies |
Sep. 22, 2009 |
| 7592007 |
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
Sep. 22, 2009 |
| 7592006 |
Composition comprising the LO-CD2a antibody |
Sep. 22, 2009 |
| 7592428 |
Antibodies which bind specifically to activin receptor like kinases |
Sep. 22, 2009 |
| 7585501 |
Compositions and methods for treating kidney disease |
Sep. 8, 2009 |
| 7563443 |
Monovalent anti-CD40L antibody polypeptides and compositions thereof |
Jul. 21, 2009 |
| 7563442 |
Antibodies to CD40 and methods of treating cancer and enhancing immune responses |
Jul. 21, 2009 |
| RE40811 |
Peripheralization of hematopoietic stem cells |
Jun. 30, 2009 |
| 7550143 |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
Jun. 23, 2009 |
| 7547437 |
Method of treating fibrosis |
Jun. 16, 2009 |
| 7547438 |
CD40-binding activating antibodies |
Jun. 16, 2009 |
| 7537763 |
Anti-CD40 monoclonal antibody |
May. 26, 2009 |
| 7534427 |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
May. 19, 2009 |
| 7527787 |
Multivalent immunoglobulin-based bioactive assemblies |
May. 5, 2009 |
| 7521051 |
Methods of upmodulating adaptive immune response using anti-PD-1 antibodies |
Apr. 21, 2009 |
| 7521052 |
Methods for treating interleukin-6 related diseases |
Apr. 21, 2009 |
| 7521056 |
Stably tethered structures of defined compositions with multiple functions or binding specificities |
Apr. 21, 2009 |
| 7510713 |
Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies |
Mar. 31, 2009 |
| 7510711 |
Methods for the treatment of cancer using anti-CD40 antibodies |
Mar. 31, 2009 |
| 7510712 |
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies |
Mar. 31, 2009 |
| 7504101 |
Methods for enhancing antigen-specific immune response using antibodies that bind OX-40 |
Mar. 17, 2009 |
| 7501123 |
Human G-protein chemokine receptor (CCR5) HDGNR10 |
Mar. 10, 2009 |
| 7501124 |
Methods of inducing T-cell non-responsiveness with anti-gp39 24-31 antibodies |
Mar. 10, 2009 |
| 7498032 |
Methods for treating immune disorders or cancer with anti-CD40 antibodies |
Mar. 3, 2009 |
| 7498031 |
Therapeutic agents for inner ear disorders containing an IL-6 antagonist as an active ingredient |
Mar. 3, 2009 |
| 7495081 |
Framework patched anti-CD20 antibody |
Feb. 24, 2009 |
| 7491514 |
Reducing the immunogenicity of anti-CD20 antibodies by framework patching |
Feb. 17, 2009 |
| 7491393 |
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies |
Feb. 17, 2009 |
| 7488804 |
Modified fusion molecules for treatment of allergic disease |
Feb. 10, 2009 |
| 7482000 |
Mutant Fab fragments of the chimeric 13B8.2 anti-CD4 antibody and their applications |
Jan. 27, 2009 |
| 7482003 |
Treatment for asthma with .alpha.4-specific antibodies |
Jan. 27, 2009 |
| 7476385 |
Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
Jan. 13, 2009 |
| 7465446 |
Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease |
Dec. 16, 2008 |
| 7465464 |
Populations of cells that express flk-2 receptors |
Dec. 16, 2008 |
| 7462353 |
Method for the treatment of inflammatory disorders |
Dec. 9, 2008 |
| 7452536 |
Methods of treating cancer by administering antibodies to CD200 |
Nov. 18, 2008 |
| 7445781 |
Anti-CD40CR MR1 antibody |
Nov. 4, 2008 |
| 7445798 |
Populations of cells that express FLK-1 receptors |
Nov. 4, 2008 |
| 7445780 |
Antagonistic anti-CD40 antibodies |
Nov. 4, 2008 |
| 7438907 |
Human monoclonal antibodies against CD25 |
Oct. 21, 2008 |
| 7438910 |
Therapeutic human anti-IL1-R1 monoclonal antibody |
Oct. 21, 2008 |
|
|
|
